Roivant Sciences Ltd. (ROIV)
Listed on NASDAQ • Healthcare / Biotechnology
Overview
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Explore More Data
Key Information
Symbol:
ROIV
CEO:
Matthew Gline
Exchange:
NASDAQ
CIK:
0001635088
Website:
https://roivant.com
SEC Filings:
View SEC →
Stock Snapshot (Updated: Nov 05 04:00 PM EST)
Price
20.23
Change
0.36
Change %
1.81%
Open
19.83
Previous Close
19.87
High
20.3
Low
19.62
Volume
8,964,051
Market Cap
13,814,696,960
EV/EBITDA
0
Capital Structure (Updated: Nov 05 04:00 PM EST)
Shares Outstanding
682,881,743
FloatShares
454,608,034
Float Ratio
66.57%
Shares Short
25,271,869
Short Percent Of Float
The percent of float shares currently sold short. Reflects market sentiment and risk of a short squeeze.
4.96%
Short Ratio
Days needed to cover all short positions. Indicates short-selling pressure.
3.02 trading days
Held Percent Insiders
26.12%
Held Percent Institutions
76.80%
Calendar Events (Upcoming Earnings & Revenue Forecasts)
| Earnings | |
| Earnings Date | 2025-11-10 |
| Earnings Call | |
| Avg EPS Estimate | -0.3041 |
| Low EPS Estimate | -0.4263 |
| High EPS Estimate | -0.24 |
| Revenue | |
| Avg Revenue Forecast | 6,915,000 |
| Low Revenue Forecast | 1,779,000 |
| High Revenue Forecast | 15,000,000 |
ROIV Liquidity Indicators Shows key metrics that reflect cash availability and short-term payment ability
| Field | Value | Description |
|---|---|---|
| Cash Holdings | $<nil> | Cash on hand, which directly shows a company's ability to meet short-term obligations. |
| Quick Ratio | The quick ratio, which excludes inventory, measures short-term solvency; a value above 1 is considered relatively safe. | |
| Current Ratio | The current ratio, calculated as current assets divided by current liabilities; the higher the value, the better the liquidity. | |
| Total Debt | $<nil> | Total liabilities, used together with cash and liquidity ratios to assess debt burden. |
ROIV Profitability Indicators Shows key metrics that reflect overall earnings, margins, and core business profitability
| Field | Value | Description |
|---|---|---|
| EBITDA | $<nil> | EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), which measures the profitability of core operations. |
| Operating Cash Flow | $<nil> | Operating cash flow, which reflects a company's cash-generating ability. |
| Free Cash Flow | $<nil> | Free cash flow, after deducting capital expenditures, which can be used for dividends or reinvestment. |
| Gross Margin |